Tifcemalimab is a Humanized Anti-BTLA Monoclonal Antibody For Cancer Research
The B- and T-lymphocyte attenuator (BTLA) is a co-suppressor receptor for B and T cell expression. HVEM (Herpesvirus Entry Mediator), the main ligand of BTLA, also binds to CD160 and…